These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Blennow K; Zetterberg H; Rinne JO; Salloway S; Wei J; Black R; Grundman M; Liu E; Arch Neurol; 2012 Aug; 69(8):1002-10. PubMed ID: 22473769 [TBL] [Abstract][Full Text] [Related]
8. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585 [TBL] [Abstract][Full Text] [Related]
9. Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption. Blattner MS; Panigrahi SK; Toedebusch CD; Hicks TJ; McLeland JS; Banks IR; Schaibley C; Ovod V; Mawuenyega KG; Bateman RJ; Wardlaw SL; Lucey BP J Alzheimers Dis; 2020; 75(2):471-482. PubMed ID: 32250301 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758 [TBL] [Abstract][Full Text] [Related]
11. An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter. Lucey BP; Gonzales C; Das U; Li J; Siemers ER; Slemmon JR; Bateman RJ; Huang Y; Fox GB; Claassen JA; Slats D; Verbeek MM; Tong G; Soares H; Savage MJ; Kennedy M; Forman M; Sjögren M; Margolin R; Chen X; Farlow MR; Dean RA; Waring JF Alzheimers Res Ther; 2015; 7(1):53. PubMed ID: 26225140 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. Paternicò D; Galluzzi S; Drago V; Bocchio-Chiavetto L; Zanardini R; Pedrini L; Baronio M; Amicucci G; Frisoni GB Alzheimers Dement; 2012 Nov; 8(6):520-7. PubMed ID: 22677492 [TBL] [Abstract][Full Text] [Related]
13. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147 [TBL] [Abstract][Full Text] [Related]
14. A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls. Pannee J; Portelius E; Oppermann M; Atkins A; Hornshaw M; Zegers I; Höjrup P; Minthon L; Hansson O; Zetterberg H; Blennow K; Gobom J J Alzheimers Dis; 2013; 33(4):1021-32. PubMed ID: 23076076 [TBL] [Abstract][Full Text] [Related]
17. Plasma beta carotene in Alzheimer's disease. Association with cerebrospinal fluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau. Stuerenburg HJ; Ganzer S; Müller-Thomsen T Neuro Endocrinol Lett; 2005 Dec; 26(6):696-8. PubMed ID: 16380679 [TBL] [Abstract][Full Text] [Related]
18. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377 [TBL] [Abstract][Full Text] [Related]
19. Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life. Mielke MM; Zandi PP; Blennow K; Gustafson D; Sjögren M; Rosengren L; Skoog I Alzheimer Dis Assoc Disord; 2006; 20(1):30-6. PubMed ID: 16493233 [TBL] [Abstract][Full Text] [Related]
20. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]